Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05643456
Other study ID # RIO
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 1, 2020
Est. completion date December 30, 2021

Study information

Verified date December 2022
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Comparison Between The Results Of Two Muscles Surgery And Three Muscles Surgery For The Treatment Of Large Angle Exotropia


Description:

Exotropia is classified as Primary which includes constant and intermittent exotropias. Secondary XT include Sensory and consecutive XT. Management for IXT consists of non-surgical and surgical treatment. There is some controversy regarding the optimal surgical method varying between bilateral lateral rectus recession (BLR), unilateral lateral rectus recession-medial rectus resection (RR) and bilateral medial rectus resection (BMR).


Recruitment information / eligibility

Status Completed
Enrollment 69
Est. completion date December 30, 2021
Est. primary completion date December 1, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 5 Years and older
Eligibility Inclusion Criteria: - Patients above age of 5 years with concomitant Exotropia of (40-55) PD of any type. Exclusion Criteria: 1. Angle of deviation less than 40 PD or more than 55 PD. 2. History of previous surgery. 3. Inconcomitant exotropia. 4. Incomitance in any gaze. 5. Associated vertical deviation(oblique dysfunction,A or V pattern). 6. Patients with neurological deficit.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
surgery
69 Patients with exotropia of (40-55) PD who are = 5 years old. The 1st group 30 patients had two muscles surgery; bilateral lateral rectus recession. The 2nd group 39 patients had three muscles surgery; bilateral lateral rectus recession and unilateral medial rectus tucking.

Locations

Country Name City State
Egypt Reham fawzy elsherbiny Giza

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary alignment in the primary position measuring any misalignment by prism bar 1 week to 6 months
Primary palpebral fissure height measuring with millimeter 1 week to 6 months
Primary End gaze deficit measuring with prism bar 1 week to 6 months
See also
  Status Clinical Trial Phase
Completed NCT01460355 - Comparison of Two Treatments for Strabismus Correction: Botulinum Toxin A Associated to Surgery and Surgery Alone Phase 4
Not yet recruiting NCT06084442 - Evaluation of The Techniques in Correcting Large-Angle Exotropia N/A
Completed NCT02570555 - Strabismus Surgery and Driving Ability
Not yet recruiting NCT05089422 - Study of Clinical Types and Surgical Out Come of Pediatric Exotropia N/A
Not yet recruiting NCT06312865 - Intermittent Exotropia in Egyptian Population
Recruiting NCT05379855 - A-eyedrops on Ocular Alignment and Binocular Vision N/A
Completed NCT01032603 - Bilateral Lateral Rectus Recession Versus Unilateral Recess-Resect for Intermittent Exotropia N/A
Completed NCT01032330 - Observation Versus Occlusion Therapy for Intermittent Exotropia N/A
Not yet recruiting NCT03768362 - Comparison of Medial Rectus Resection and Plication in Exotropic Patients Phase 2/Phase 3
Recruiting NCT05615519 - Validation of a Smartphone-based Intelligent Diagnosis and Measurement for Strabismus
Recruiting NCT05242510 - Evaluation of Exotropia After Patching the Eye or After Prism Adaptation N/A
Completed NCT03119311 - A Novel Diagnostic Method for Exotropia Using Video-oculography N/A
Recruiting NCT01616108 - Bupivacaine Injection of Eye Muscles to Treat Strabismus Phase 2/Phase 3